Meguro Counseling Center

Douglas Berger psychiatrist Tokyo is the Director of the Tokyo Meguro Counseling Center

Douglas Berger psychiatrist Tokyo - Meguro Counseling Center logo

The Tokyo Meguro Counseling Center is a counseling and psychology mental health service in Tokyo that provides caring and compassionate professional English speaking psychotherapy and Psychopharmacology-Integrated Psychotherapy by American therapists native to and professionally trained in the United States. The Center has provided counselling and psychological care in Tokyo for the international community, as well as counseling in Japanese for the local Japanese community since opening in 1992, and in New York City for many years before relocating to Tokyo. The therapists at the Tokyo Meguro Counseling Center are experienced in individual counseling for children, adolescents, and adults, marriage and couples counseling (particularly inter-cultural counseling for Japanese-Western couples), family counseling, divorce counseling, life counseling, career counseling and coaching, and group psychotherapy. Corporate training and conflict resolution is also available, please inquire for details. Phone or Skype distance counseling is often conducted for persons living in Kansai (Kobe, Osaka, and Kyoto) and other areas of Japan that are far from our location in Tokyo.

Some of the more common problems that the therapists at the Tokyo Meguro Counseling Center have experience treating include self-confidence problems, relationship/family problems, depression and manic depression, anxiety (GAD) and panic disorder, eating disorders, obsessive compulsive disorder (OCD) phobias, social anxiety disorder (SAD), alcohol and substance abuse, ADD and ADHD treatment, traumatic experiences (PTSD)/child abuse, feelings of unreality, sleep disturbances, psychosomatic (mind/body) disorders, women’s issues, gay, lesbian and transgender issues, sex addiction, and child and adolescent disturbances. The Tokyo Meguro Counseling Center therapists have considerable experience in the treatment of anxiety and depression in Tokyo. See an article on Depession in the Tokyo Families Magazine.

Clients who entrust the Meguro Counseling Center with their counseling needs are treated kindly and professionally, and the work at hand in the care of these persons and their issues is taken extremely seriously.

To contact Douglas Berger psychiatrist Tokyo please click here.

Douglas Berger Tokyo psychiatrist: Brain changes in Mindfulness Based therapy https://t.co/zpuzl9UBif

Douglas Berger Tokyo psychiatrist: Many therapy studies call themselves, “single-blind” https://t.co/uKasdYEwnY

Many therapy studies call themselves, “single-blind”, however, this when the subject is blind, not when assessors are blind. “Single-blind” is misleading the reader that there is some control of bias when there is not. Us: https://t.co/sooQBqR2nb.

Douglas Berger Tokyo psychiatrist: Antidepressants show efficacy under double blind https://t.co/mgUktrrS97

Douglas Berger Tokyo psychiatrist: Blind placebo pills give 30% improvement in depression https://t.co/DopRqQA0E0

Load More...

Brain changes in Mindfulness Based therapy was unblinded with only 16 subjects: https://t.co/CC4HlhldEi. If you look at many brain sections you may find something by chance, you need to half your p value for each section looked at, not done here. Us: https://t.co/kbQF1wSzGN

Tokyo Counseling Service on ADHD https://t.co/LPwy8DzMbB @YouTubeさんから

Antidepressants show efficacy under double blind vs blind placebo because blinding filters out hope and expectation. Neither randomization nor blind assessment can make up for the loss of control from no-blind, no placebo conditions. Us: https://t.co/tReJReVhnP

Blind placebo pills give 30% improvement in depression. In depression drug trials, “non-inferiority” is very easily obtained as everyone responds to the placebo effect. Superiority studies have a higher statistical hurdle than non-inferiority studies. Us: https://t.co/CcbDgs5z45.

Medication vs psychotherapy isn't valid in a clinical trial because you can't double blind all the arms. Its uncontrolled clinical data, endpoints are subjective, and medications require double blinding or blind placebo: https://t.co/WLIjKdXqXL.

Load More...